Hormonal acne, decoded.

The honest TLDR.

Hormonal acne is the persistent, predictable pattern of breakouts that runs along the jaw, chin and neck and tracks with your menstrual cycle. It is not the scattered T-zone congestion you may have had as a teenager. It is deeper, more painful, more cyclical, and meaningfully more frustrating — partly because the skincare aisle is not built to address it. The good news, if you can call it that, is that the underlying drivers are reasonably well understood and many of them are measurable.

In U.S. women aged roughly 25-45, three biomarker patterns drive most cases. The first is androgen-related — testosterone (total and free) and DHEA-S sitting higher than the body is comfortable processing, or being processed more aggressively at the skin level. The second is insulin sensitivity, which sits at the centre of PCOS and pushes androgens upward as a downstream effect. The third is cortisol and chronic stress, which acts on the same skin-level machinery from a different angle. The remaining roughly 30% of cases sit in dermatological, lifestyle, microbiome, or other categories.

The pattern Heme keeps seeing: most women have been treated for one of these and not investigated for the others. Topicals get prescribed. Spironolactone may come up. The conversation about insulin sensitivity, full thyroid function, or cortisol patterning usually doesn't. This hub is a starting point for that wider conversation — what to understand, what to test, and what to ask. The fastest route in is the Heme Quiz. Otherwise, read on.

What "hormonal acne" actually means.

Most acne after the age of 25 has some hormonal component. The term "hormonal acne" usually describes a specific phenotype: deep, cystic, sometimes painful spots concentrated along the jawline, chin and neck, often with a recognisable flare in the five to seven days before menstruation. This is different from the surface-level T-zone congestion that defines teenage acne. The location, the depth, and the cycle-tracking pattern are what give it away.

The skin biology in plain English: androgens (testosterone and its derivatives, plus DHEA-S from the adrenal glands) bind to receptors in the sebaceous glands of the skin and tell them to produce more sebum. Sebum on its own isn't the problem. Sebum combined with dead skin cells, clogged pores and the skin bacterium Cutibacterium acnes creates the inflammatory cascade that becomes a visible spot. The jaw and chin are particularly androgen-receptor-dense areas, which is why hormonal acne clusters there rather than spreading across the forehead.

The piece most women aren't told: you can have a measurable hormonal driver even if your androgen levels look "normal" on paper. Skin-level androgen sensitivity varies meaningfully from woman to woman. A testosterone level that one woman processes uneventfully may produce significant cystic acne in another, because her sebaceous glands are more responsive at the receptor level. Hormonal acne is, in that sense, an upstream signal of an imbalance in either production or sensitivity — and the conversation worth having is which one it is for you.

"The jaw and chin are particularly androgen-receptor-dense — which is why hormonal acne clusters there rather than spreading across the forehead."

The four most common patterns.

These four patterns cover most of the hormonal acne presentations seen in U.S. women aged 25-45. Yours may be a combination of two, and frequently is — particularly stress-driven flares layered on top of an underlying PCOS or mid-luteal pattern.

3.1 PCOS-pattern (insulin + androgens)

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age in the U.S., and it sits upstream of a meaningful share of adult hormonal acne. The mechanism in plain English: when the body is producing more insulin than it needs to keep blood sugar in range — the early stage of insulin resistance — that extra insulin signals the ovaries to produce more androgens. Higher androgens then drive the skin pattern, the cycle pattern, and frequently the hair pattern that defines PCOS.

The recognisable phenotype: cystic acne on the jaw and chin, irregular or skipped periods (more than 35 days between, or fewer than eight cycles a year), weight that's harder to shift than the inputs would suggest, and dark, coarser hair growth in androgen-sensitive areas — upper lip, chin, lower abdomen, inner thighs. Not every woman with PCOS has every feature. Many have a quieter version that gets missed for years. The blood work worth understanding here covers fasting insulin, HbA1c, free and total testosterone, and SHBG. We'll get to the panel below.

3.2 Mid-luteal flare (cycle-driven)

This is the most predictable version. Cycles are regular. Hormones are technically in range. But acne flares reliably in the five to seven days before menstruation and quiets down once bleeding starts. The mechanism: progesterone rises through the second half of the cycle (the luteal phase) and shifts the ratio of progesterone to estrogen in ways that increase sebum production. At the same time, estrogen — which is broadly protective of skin clarity — is dropping. The combined effect lands on day 21-24 of a 28-day cycle as a predictable cluster of jawline spots.

The reason this pattern gets under-investigated is that, by definition, your overall hormones are "normal" — they're just moving through a normal cycle that your skin happens to be sensitive to. Blood work here is less about flagging a deficiency and more about understanding the cycle's range: a mid-luteal progesterone draw on roughly day 21 confirms the phase, and SHBG context can hint at how much free androgen the body is exposing skin to. In clinical practice, treatment conversations here often focus on whether the cycle-driven pattern is mild enough to manage with topicals and consistency, or sustained enough to warrant a discussion of hormonal contraception or spironolactone.

3.3 Stress-driven (cortisol)

This pattern correlates with work demands, sleep loss, and life chaos in a way most women already suspect. The biology underneath it: chronic stress keeps cortisol elevated beyond its useful morning peak. Sustained cortisol promotes inflammation, raises insulin, and increases adrenal androgen output — meaning the same skin machinery gets activated through a different door. Stress-driven acne tends to flare in waves that track to specific life pressures rather than to the cycle itself, and it often layers on top of an existing PCOS or mid-luteal pattern.

What makes this pattern hard to disentangle is that the standard "random cortisol" blood draw tells you very little. A single morning value can sit within range while the daily curve is meaningfully flat or dysregulated. Where it's available, a four-point salivary cortisol pattern across the day is more informative than one venous draw. The honest caveat in plain English: cortisol patterns are useful context, not a clean diagnostic — and the most reliable lever is generally the slower one, around sleep architecture, training load and the underlying drivers of the stress itself.

3.4 Post-pill rebound

This is the pattern that shows up three to twelve months after stopping a hormonal contraceptive — particularly the combined pill, which suppresses ovarian androgen production and raises SHBG (the protein that binds free testosterone and keeps it inactive). When the pill comes off, both effects reverse. SHBG drops, free androgen rises, and the sebaceous glands respond. For women who had clear skin on the pill and remember being told they didn't have hormonal acne at all, the rebound can be genuinely disorienting.

What's worth knowing: the rebound usually peaks around month six and settles by month twelve as the body re-establishes its own cycle. For some women it doesn't settle, and that's the point at which a panel is most useful — to understand whether what's emerging is the underlying picture the pill was masking, including a previously undiagnosed PCOS pattern. Testing too early in the rebound window can produce snapshot numbers that don't reflect where the body will stabilise. Worth discussing with a provider before drawing.

The blood work that might matter.

You don't need every marker on this list to start. You need enough of them to triangulate which of the four patterns above is in play, and what's worth doing about it. A reasonable comprehensive panel for an otherwise-healthy woman with persistent jaw/chin acne usually covers most of the following:

Almost none of these are useful as a single isolated number. They are useful as a panel, read together by someone who can put them in the context of your cycle, your symptoms and your history. The timing of the draw, particularly for progesterone and cortisol, can change the read meaningfully.

Where dermatology helps and where it doesn't.

Dermatology is the front line of acne care in the U.S., and for good reason — the available toolkit is genuinely effective at the skin level. The honest framing, though, is to understand which part of the chain each intervention addresses, because hormonal acne is fundamentally an upstream problem that dermatology meets downstream.

Topicals — retinoids, benzoyl peroxide, azelaic acid, topical antibiotics — work on the downstream end. They reduce clogged pores, normalise skin cell turnover, dial down bacteria and quiet inflammation in the spot itself. They are evidence-supported as part of an acne regimen, and they are the right starting point for most presentations. What they do not do is change the hormonal signal that's telling your sebaceous glands to over-produce in the first place. Many women with hormonal acne see meaningful improvement on topicals and then plateau — because the upstream driver hasn't moved.

Spironolactone — an oral medication originally developed as a diuretic — addresses the upstream androgen signal directly by blocking androgen receptors in the skin. In clinical practice it is one of the most useful tools available for adult women with the jaw/chin pattern, and the evidence base for it in this context has grown meaningfully. It comes with trade-offs worth discussing with a clinician: it can affect potassium, it's not appropriate during pregnancy, and the response takes three to six months to read.

Accutane (isotretinoin) sits at the most aggressive end of the dermatology toolkit and works primarily by shrinking sebaceous gland output. It is genuinely effective for severe cystic acne and has the most durable response of any acne intervention. It also has the most significant side-effect profile, requires ongoing monitoring, and is teratogenic — meaning strict pregnancy prevention protocols apply throughout treatment. The conversation about whether it's the right tool is one only a prescribing dermatologist can have with you.

None of these solve the upstream insulin/PCOS driver, the stress driver, or the thyroid context if any of those is in play. That isn't a criticism of dermatology — it's a reminder that the chain has multiple links.

Where biomarker testing helps and where it doesn't.

Testing provides context for a clinical conversation. It does not provide a treatment. The most useful framing, in clinical practice, is that a panel of markers helps your provider see whether the acne pattern sits inside a wider systemic picture — PCOS, thyroid drift, cortisol dysregulation — or whether it's primarily a skin-level conversation. That distinction changes the plan that gets made.

Where testing is most useful: when symptoms have already been treated with topicals for a meaningful stretch with limited response, when there are accompanying systemic signs (irregular cycles, weight changes, hair growth pattern shifts, persistent fatigue, brain fog), or when a woman is post-pill and trying to understand what the underlying picture looks like now that the pill is no longer masking it. In these contexts, a panel can meaningfully widen the conversation a provider is able to have with you.

Where testing is less useful: as a substitute for actually seeing a dermatologist or OB-GYN when acne is significant. It's tempting, in the U.S. direct-to-consumer landscape, to treat a comprehensive panel as a diagnosis. It isn't one. Many women with hormonal acne have results that sit "within range" on every marker — the pattern is sensitivity, not absolute levels, and the path forward in that case is still a clinical conversation about the skin pattern itself. Bloodwork is a useful input. It is not the answer.

The cleanest framing: tests inform the conversation, dermatology and OB-GYN treat the conditions. If you can only afford to do one thing, the appointment is generally more useful than the panel. If you can afford both, doing the panel before the appointment tends to widen what the appointment can productively cover.

When to escalate to a clinician.

Heme is an editorial layer, not a clinic. The point of understanding your blood work is to give the clinician you do see a sharper picture than a rushed appointment usually produces — not to replace the appointment. There are specific situations where escalating sooner rather than later is genuinely warranted.

To be clear: bloodwork is the starting point of this conversation, not the endpoint. A dermatologist, OB-GYN, or women's-health nurse practitioner is the right next step once results are in hand. If the first provider you see waves off the pattern as "just adult acne" without engaging with the systemic picture, a second opinion is reasonable — particularly where PCOS or thyroid context is on the table.

These aren't a script. Your clinician will steer the conversation where it's most useful. They are a starting point that tends to produce a wider and more useful plan than the default appointment, particularly if the conversation so far has been confined to topicals.